“concert-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop 12/20/17 Boston
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
Big Events, Exits Raising Boston’s Innovation Profile at Year’s End 12/12/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy 02/26/13 Boston
BG Medicine, Bottomline, 4s3 Bioscience Among the Week’s Dealmakers 03/07/12 Boston
Concert, Alere, TremRx, & More Names from Boston Life Sciences News 03/02/12 Boston
SD Life Sciences (and Cleantech) Roundup: DexCom, Ligand, Genomatica 03/01/12 San Diego
Concert Nabs $200M Deal From Avanir to Make Psych Drugs 02/29/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex 08/04/10 Boston
Page 1 of 2 next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.